Clinical benefits of the Closed Loop Stimulation in Sinus Node Disease - discussion

9 April 2024 (10:53 - 10:57)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Niraj Varma

Cleveland Clinic, Cleveland (United States of America)

9 More presentations in this session

Presentation thumbnail

Clinical benefits of the Closed Loop Stimulation in Sinus Node Disease

Doctor E. Pisano (Lecce, IT)

Presentation thumbnail

Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial.

Doctor J. Nikorowitsch (Hamburg, DE)

Presentation thumbnail

Effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation. The NOAH-AFNET 6 trial. - discussion

Doctor S. Al-Khatib (Durham, US)

Presentation thumbnail

Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: Insights from the ARTESiA trial

Doctor W. McIntyre (Hamilton, CA)

Presentation thumbnail

Risk of stroke or systemic embolism according to baseline frequency and duration of subclinical atrial fibrillation: Insights from the ARTESiA trial - discussion

Professor T. Potpara (Belgrade, RS)

Access the full session

Session thumbnail

Late-Breaking Science: devices

The Event

Event poster

EHRA 2024

9 April 2024 10:53 CET

You may be interested in

Congress Presentation

Clinical benefits of the Closed Loop Stimulation in Sinus Node Disease

Congress Session

Scanning the horizon: trials that will improve care of atrial fibrillation patients

Congress Session

Late-Breaking Clinical Trials: recent advances in CIED therapies

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources